Declassified State Department records question key impeachment testimony
On Oct. 16, 2026 the White House Government Transparency Task Force released declassified State Department emails and memos that call into question the accuracy and completeness of key testimony used in the 2019 impeachment of President Donald Trump.
The new records arrive as the impeachment remains a focal point of political debate, and they suggest that some of the evidence presented to Congress may have been incomplete or misleading. Lawmakers and historians alike are likely to reassess the narrative in light of the fresh documentation.
Former Ambassador to Ukraine Marie Yovanovitch told investigators in an Oct. 11, 2019 deposition that the Burisma‑Biden matter “just wasn’t a big deal.” The released files, however, show that Yovanovitch and her aides exchanged dozens of communications from 2016 to 2019 about Burisma, Hunter Biden, and related lobbying efforts. An August 2017 memo forwarded to her detailed a criminal case against Burisma founder Mykola Zlochevsky and referenced $13 million moving through U.S. financial institutions, contradicting her claim that she had not been briefed.
Deputy Chief of Mission George Kent also provided statements that now appear inconsistent. In November 2019 he told investigators that a conflict of interest involving Hunter Biden had not influenced U.S. policy. Yet a Nov. 22, 2016 note from Kent warned that Biden’s son’s board seat “undercut” the anti‑corruption message the United States was promoting in Ukraine.
The task force’s release also includes declassified memos flagging potential bias in the whistleblower whose complaint sparked the impeachment. The documents show the whistleblower, Eric Ciaramella, acknowledged prior contact with staffers on the Democratic‑led House Intelligence Committee and admitted to concealing his complaint from Republican members, raising questions about the impartiality of his allegations.
Officials said the task force will continue to make additional records public, and congressional committees are expected to review the new evidence to determine whether further action is warranted.
